Atrys Health (Spain) Today
| ATRY Stock | EUR 3.09 0.05 1.59% |
Performance0 of 100
| Odds Of DistressOver 58
|
Atrys Health is trading at 3.09 as of the 30th of November 2024, a 1.59 percent decrease since the beginning of the trading day. The stock's open price was 3.14. Atrys Health has over 58 % chance of experiencing financial distress in the next 2 years of operation and has generated negative returns for investors over the last 90 days. Equity ratings for Atrys Health SL are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of September 2024 and ending today, the 30th of November 2024. Click here to learn more.
Atrys Health, S.A., a biomedical company, provides diagnostic services and medical treatments. Atrys Health, S.A. was incorporated in 2007 and is headquartered in Madrid, Spain. ATRYS HEALTH operates under Biotechnology classification in Spain and is traded on Madrid SE C.A.T.S.. The company has 75.89 M outstanding shares. More on Atrys Health SL
Moving against Atrys Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Atrys Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Atrys Health's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Atrys Health or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chief Executive Officer | Isabel Fernandez |
| Thematic Idea | Health Management (View all Themes) |
| Business Concentration | Health Management, Biotechnology, Healthcare (View all Sectors) |
Atrys Health SL (ATRY) is traded on Madrid Exchange in Spain and employs 2,397 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 461.42 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Atrys Health's market, we take the total number of its shares issued and multiply it by Atrys Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Atrys Health SL operates under Healthcare sector and is part of Biotechnology industry. The entity has 75.89 M outstanding shares.
Atrys Health SL has accumulated about 17.6 M in cash with 4.69 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.51.
Check Atrys Health Probability Of Bankruptcy
Ownership AllocationAtrys Health holds a total of 75.89 Million outstanding shares. Atrys Health SL shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 78.47 percent of Atrys Health SL outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Atrys Ownership Details
Atrys Health SL Risk Profiles
Although Atrys Health's alpha and beta are two of the key measurements used to evaluate Atrys Health's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.33 | |||
| Standard Deviation | 1.72 | |||
| Variance | 2.97 | |||
| Risk Adjusted Performance | (0.05) |
Atrys Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Atrys Health without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Pair Correlation Now
Pair CorrelationCompare performance and examine fundamental relationship between any two equity instruments |
| All Next | Launch Module |
Atrys Health Corporate Management
Elected by the shareholders, the Atrys Health's board of directors comprises two types of representatives: Atrys Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Atrys. The board's role is to monitor Atrys Health's management team and ensure that shareholders' interests are well served. Atrys Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Atrys Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Helena VidalFolch | Head Communication | Profile | |
| Gabriela Camunas | G Counsel | Profile | |
| Encarna Vega | Adm Director | Profile | |
| Maria Marin | Head Relations | Profile |
Other Information on Investing in Atrys Stock
Atrys Health financial ratios help investors to determine whether Atrys Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Atrys with respect to the benefits of owning Atrys Health security.